Results 171 to 180 of about 8,957 (228)

Semi-mechanistic modeling to investigate differential dynamics of anti-citrullinated protein antibody (ACPA) IgG versus total IgG reduction following nipocalimab treatment

Semi-mechanistic modeling to investigate differential dynamics of anti-citrullinated protein antibody (ACPA) IgG versus total IgG reduction following nipocalimab treatment
Angelia F. Wang, Weirong Wang, Jocelyn Leu, Sophia Liva, Rohit Panchakshari, Vivaswath Ayyar   +5 more
openaire   +1 more source

Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis. [PDF]

Arthritis Res Ther
van Wesemael TJ, Morton FR, Heutz JW, Maurits MP, Dorjée AL, Porter D, Huizinga TWJ, Raza K, Toes REM, Knevel R, de Jong PHP, Svärd A, van der Woude D.   +12 more
europepmc   +1 more source

Impact of HLA-DRB1 SE, anti-citrullinated protein antibodies and smoking on radiographic outcome in Greek patients with Rheumatoid Arthritis. [PDF]

BMC Rheumatol
Mole EN, Tarassi K, Tsirogianni A, Athanassiades T, Kitsiou V, Kouniaki D, Gazi S, Vlachoyiannopoulos P.   +7 more
europepmc   +1 more source

HLA-B*44 is associated with a more than twentyfold increase in cyclic citrullinated peptide antibody serum level in Croatian patients with seropositive rheumatoid arthritis. [PDF]

PLoS One
Aljinović J, Kero D, Šošo D, Petrić M, Marasović Krstulović D, Perković D, Čečuk-Jeličić E, Jaman S, Dujmović D, Marinović I.   +9 more
europepmc   +1 more source

Rheumatoid Arthritis referral criteria: systematic review of the literature. [PDF]

BMC Rheumatol
Madruga Dias J, Ribeiro R, Costa T, Silvério Serra S, Silva S, Iagnocco A, Canhão H, Pimentel-Santos F.   +7 more
europepmc   +1 more source

ACPA-pozitív és -negatív rheumatoid arthritis: két betegség, vagy ugyanazon kórkép két fenotípusa? [PDF]

, 2017
Szekanecz, Zoltán
core  

Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial. [PDF]

Rheumatology (Oxford)
Watanabe R, Tanaka Y, Takeuchi T, Okamoto S, Kyuuma M, Matsumoto R, Nakayama Y, Katsushima M, Hashimoto M.   +8 more
europepmc   +1 more source

Prevalence and impact of thyroid dysfunction in patients with rheumatoid arthritis. [PDF]

Sci Rep
Rahmouni S, Dhifallah M, Mrad M, Bouallègue E, Zouaoui K, Krir A, Rekik S, Wahabi H, Boussaid S, Sahli H, Bahlous A.   +10 more
europepmc   +1 more source

Specific modification of protein-bound citrulline residues facilitates their detection [PDF]

, 2009
De Ceuleneer, Marlies, Deforce, Dieter, Tilleman, Kelly, Van Steendam, Katleen   +3 more
core   +2 more sources

Cystatin D as a biomarker for rheumatoid arthritis: relation to disease activity and joint damage. [PDF]

Reumatologia
Mounir O, Sedky A, Mohafez OM, Elsayed SA.   +3 more
europepmc   +1 more source